Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON42854
NL-OMON42854
Completed
Not Applicable

A single centre, open label trial investigating the absorption, metabolism and excretion of somapacitan after single subcutaneous dosing in healthy male subjects - Somapacitan 3H-AME study

ovo Nordisk A/S0 sites7 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionsgroeihormoondeficientiegrowth hormone deficiency

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
groeihormoondeficientie
Sponsor
ovo Nordisk A/S
Enrollment
7
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • •healthy male subjects
  • •45\-64 yrs, inclusive
  • •BMI: 20\.0\-29\.9 kg/m2, inclusive

Exclusion Criteria

  • •Suffering from hepatitis B, hepatitis C, cancer or HIV/AIDS. In case of participation in another drug study within 90 days before the start of this study or being a blood donor within 60 days from the start of the study. In case of donating more than 400 mL of blood in the 90 days prior the start of this study.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
The effect of Rhodiola rosea Extract WS 1375 on attention and mental resource allocatio
ISRCTN29449049Dr. Willmar Schwabe GmbH & Co. KG (Germany)50
Recruiting
Phase 1
A pilot single center, open label trial to assess the impact of doxycycline postexposure prophylaxis on antimicrobial resistance (SafeDoxyPEP trial)Bacterial sexually transmittable diseases (chlamydia, gonorrhea, syphilis)Therapeutic area: Diseases [C] - Bacterial Infections and Mycoses [C01]
CTIS2023-507137-24-00Institute Of Tropical Medicine78
Active, not recruiting
Not Applicable
Medical research trial for testing drug treatment of alpha-Mannosidosisalpha-MannosidosisMedDRA version: 17.1Level: LLTClassification code 10032658Term: Other specified disorders of carbohydrate transport and metabolismSystem Organ Class: 100000004850Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]
EUCTR2014-003950-15-DKZymenex A/S
Completed
Not Applicable
A pilot study to evaluate the safety and advantages of CurQfen on brain function in middle aged to elderly people.
CTRI/2018/03/012393Akay Flavours and Aromatics Private Limited6
Active, not recruiting
Phase 1
A single center, open-label trial in subjects with severe renal impairment evaluating the dialysability of the sugammadex-rocuronium complexot applicable
EUCTR2007-006934-33-BEV Organon15